Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Post-marketing, Prospective, Two-Armed Comparison Study to Assess Impact of SARS-CoV-2 or COVID-19 on Cognitive Function in Patients

NCT04950673 is registered in ClinicalTrials.gov with Cognivue, Inc. as lead sponsor.

NCT NCT04950673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04950673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Post-marketing, Prospective, Two-Armed Comparison Study to Assess Impact of SARS-CoV-2 or COVID-19 on Cognitive Function in Patients
Lead sponsor
Cognivue, Inc.
Phase
Observational
Overall status
Unknown status
Start date
July 21, 2021
Completion date
April 30, 2024
Enrollment
1,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

brain health, cognitive decline, cognitive dysfunction, covid long-haul, post cov-2 syndrome